Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 110 participants.
Also called NCT07308184
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT07308184
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07308184. Randomized; quadruple masking; primary purpose treatment. Start 2025-12 (anticipated); primary completion 2027-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone
- Condition
- Diabetes (DM)
- Condition
- Diabetes Mellitus Type 2
- Intervention (Drug)
- IN-B00009
- Intervention (Drug)
- Placebo
- Lead sponsor
- HK inno.N Corporation
Record details
- Record id
cardio:ct-nct07308184- Content hash
2241224c056de7686637dfe878f7dc88c9b1c6b54583f2436b5811d59729a8c7